These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14679105)

  • 1. Prevention of autoimmune diabetes through immunostimulation with Q fever complement-fixing antigen.
    Silva DG; Charlton B; Cowden W; Petrovsky N
    Ann N Y Acad Sci; 2003 Nov; 1005():423-30. PubMed ID: 14679105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine therapies for the prevention of type 1 diabetes mellitus.
    Petrovsky N; Silva D; Schatz DA
    Paediatr Drugs; 2003; 5(9):575-82. PubMed ID: 12956615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Q fever vaccine on trial for type I diabetes.
    Bonn D
    Mol Med Today; 1999 Apr; 5(4):143. PubMed ID: 10203740
    [No Abstract]   [Full Text] [Related]  

  • 4. A live vaccine 1-M-44 against Q-fever for oral use.
    Genig VA
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(3):265-73. PubMed ID: 5753316
    [No Abstract]   [Full Text] [Related]  

  • 5. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
    Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
    J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras).
    Rapoport MJ; Weiss L; Mor A; Bistritzer T; Ramot Y; Slavin S
    J Immunol; 1996 Nov; 157(10):4721-5. PubMed ID: 8906854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune modulation for prevention of type 1 diabetes mellitus.
    Raz I; Eldor R; Naparstek Y
    Trends Biotechnol; 2005 Mar; 23(3):128-34. PubMed ID: 15734555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes vaccines: a future to be realized.
    Lin-Su K; Kukreja A; Maclaren NK
    Diabetes Technol Ther; 2001; 3(3):451-61. PubMed ID: 11762523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development and duration of complement fixing and agglutinating antibodies in treated and non-treated Q-fever patients].
    SIEGERT R; SIMROCK W; SCHWEINSBERG H
    Zentralbl Bakteriol Parasitenkd Infektionskr Hyg; 1953 Jan; 159(3):159-69. PubMed ID: 13079144
    [No Abstract]   [Full Text] [Related]  

  • 10. Construction of a novel vaccine by conjugating a B-cell epitope of DPP4 to peptide IA2(5)-P2-1 to significantly control type 1 diabetes in NOD mice.
    Li Y; Cao H; Li Y; Li Z; Wei X; Jiao R; Cheng P; Liu X; Ma Y; Xing Y; Tang J; Wang M; Li T
    Vaccine; 2017 Dec; 35(51):7187-7197. PubMed ID: 29169891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice.
    Liu KF; Liu XR; Li GL; Lu SP; Jin L; Wu J
    Immunol Lett; 2016 Jun; 174():28-36. PubMed ID: 27085380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal or oral delivery of GAD-encoding genetic vaccines suppresses type 1 diabetes.
    Li AF; Escher A
    DNA Cell Biol; 2003 Apr; 22(4):227-32. PubMed ID: 12823899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
    Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
    Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
    Prud'homme GJ; Chang Y; Li X
    Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY; Singh B
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection.
    Balasa B; Boehm BO; Fortnagel A; Karges W; Van Gunst K; Jung N; Camacho SA; Webb SR; Sarvetnick N
    Clin Immunol; 2001 May; 99(2):241-52. PubMed ID: 11318596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
    Li AF; Hough J; Henderson D; Escher A
    Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
    Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
    Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited effect of CpG ODN in preventing type 1 diabetes in NOD mice.
    Lee BJ; Kim SK; Kim MK; Park ES; Cho HC; Shim MS; Kim MJ; Shin YG; Chung CH
    Yonsei Med J; 2005 Jun; 46(3):341-6. PubMed ID: 15988804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.